Endocare
This article was originally published in The Gray Sheet
Executive Summary
Completes $5 mil. convertible debenture financing with an option for an additional $5 mil. investment by the same institutional investor, the firm reports. Proceeds will be used to support an "aggressive" launch of the firm's Cryocare technology for prostate cancer in conjunction with the July 1 start of a Medicare national coverage policy providing reimbursement of cryosurgical treatments for prostate cancer ("The Gray Sheet" Feb. 15, p. 15). The system, which uses extremly cold temperatures to freeze and destroy selected tissue, was 510(k)-cleared in mid-1995 for ablation of the entire prostate to treat prostate cancer, and in April 1998 for treatment of benign prostatic hyperplasia ("The Gray Sheet" May 4, 1998, In Brief). A portion of the proceeds also will be used to support the upcoming international launch of the Horizon prostatic stent for acute urinary retention. CIBC Oppenheimer acted as placement agent for the transaction
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.